Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech episode artwork

EPISODE · Jul 16, 2013 · 5 MIN

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

from The Biopharma Pod · host William Reed Ltd

Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

NOW PLAYING

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

0:00 5:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Biopharma Pod?

This episode is 5 minutes long.

When was this The Biopharma Pod episode published?

This episode was published on July 16, 2013.

What is this episode about?

Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Can I download this The Biopharma Pod episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!